IRIS
CASTAGNA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.662
NA - Nord America 7.754
EU - Europa 5.701
SA - Sud America 3.393
AF - Africa 253
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 28.792
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.372
SG - Singapore 4.730
CN - Cina 3.533
BR - Brasile 2.867
HK - Hong Kong 1.591
SE - Svezia 1.439
VN - Vietnam 909
IT - Italia 873
RO - Romania 775
RU - Federazione Russa 709
DE - Germania 649
GB - Regno Unito 276
FI - Finlandia 248
AR - Argentina 235
CA - Canada 193
IN - India 187
AT - Austria 164
MX - Messico 139
PL - Polonia 123
ID - Indonesia 120
BD - Bangladesh 108
ZA - Sudafrica 100
EC - Ecuador 91
JP - Giappone 85
NL - Olanda 81
FR - Francia 80
IQ - Iraq 68
TR - Turchia 64
ES - Italia 60
IE - Irlanda 58
CO - Colombia 57
LT - Lituania 48
PK - Pakistan 43
PY - Paraguay 43
MA - Marocco 42
UA - Ucraina 37
VE - Venezuela 35
EG - Egitto 31
CL - Cile 27
UZ - Uzbekistan 26
IR - Iran 25
SA - Arabia Saudita 22
AE - Emirati Arabi Uniti 19
BE - Belgio 19
UY - Uruguay 16
DO - Repubblica Dominicana 15
IL - Israele 15
DZ - Algeria 14
NP - Nepal 14
PE - Perù 14
TN - Tunisia 13
AU - Australia 12
KE - Kenya 12
KZ - Kazakistan 12
AZ - Azerbaigian 11
EU - Europa 11
PH - Filippine 11
KR - Corea 10
OM - Oman 9
AL - Albania 8
CH - Svizzera 7
JO - Giordania 7
NG - Nigeria 7
BB - Barbados 6
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
KW - Kuwait 6
PA - Panama 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
ET - Etiopia 5
GA - Gabon 5
HR - Croazia 5
LB - Libano 5
MD - Moldavia 5
NO - Norvegia 5
BW - Botswana 4
DK - Danimarca 4
MY - Malesia 4
NI - Nicaragua 4
RS - Serbia 4
SV - El Salvador 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KH - Cambogia 3
SN - Senegal 3
AM - Armenia 2
GY - Guiana 2
KG - Kirghizistan 2
MW - Malawi 2
PT - Portogallo 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 28.763
Salva come PNG Salva come JPEG
Città #
Dallas 2.218
Singapore 2.133
Hong Kong 1.585
Ashburn 787
Shanghai 785
Hefei 684
Lawrence 542
Princeton 542
Shenzhen 440
Beijing 433
New York 407
Ho Chi Minh City 333
Milan 314
Moscow 309
São Paulo 264
Los Angeles 241
Munich 197
Nuremberg 194
Hanoi 189
Helsinki 153
Boardman 125
Denver 105
Warsaw 105
Rio de Janeiro 84
Tokyo 80
Montreal 75
Santa Clara 72
Orem 69
Rome 68
Johannesburg 67
Poplar 66
Brooklyn 64
Vienna 63
Washington 63
Guangzhou 62
Chennai 60
Stockholm 59
Curitiba 58
Turku 58
Belo Horizonte 55
London 55
Atlanta 54
Dublin 54
Brasília 50
Seattle 50
Houston 49
Mexico City 49
Da Nang 48
Toronto 48
Amsterdam 44
Campinas 44
Porto Alegre 43
Haiphong 42
Manchester 42
Phoenix 40
Cesano Boscone 39
Falkenstein 39
Quito 37
Chicago 34
Lappeenranta 34
Biên Hòa 33
Boston 32
Pune 31
The Dalles 29
Ankara 28
Frankfurt am Main 28
St Petersburg 27
Guayaquil 26
Querétaro 26
Salvador 26
Tashkent 26
Baghdad 25
Jakarta 25
Columbus 24
Gatchina 23
Guarulhos 23
Sorocaba 23
Thái Bình 23
Buenos Aires 22
Dhaka 22
Goiânia 22
Brescia 20
Council Bluffs 20
Hải Dương 20
New Delhi 20
San Francisco 20
Tianjin 20
Mumbai 19
Ribeirão Preto 19
Turin 19
Wolfhagen 19
Asunción 18
Manaus 18
Genoa 17
Hangzhou 17
Santo André 17
Contagem 16
Lahore 16
Raleigh 16
Brussels 15
Totale 15.993
Salva come PNG Salva come JPEG
Nome #
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients 1.308
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 446
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 241
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment 225
Monkeypox in a patient with undifferentiated connective tissue disease 216
Viral bloodstream detection in mpox patients: An observational multicentric study 195
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 114
A follow-up study in asymptomatic HIV patients 109
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 109
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 109
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 109
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 107
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients 105
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 98
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 94
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 90
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 88
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 88
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 87
Biobanking for COVID-19 research 86
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 81
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 81
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 80
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 79
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 79
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 78
A whole-genome association study of major determinants for host control of HIV-1 77
Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy 76
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients 76
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 76
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 76
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics 75
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 74
Achieving virological control in pan-resistant HIV-1 infection: A case series 73
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 73
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort 73
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 73
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach 72
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 72
Week 96 safety and efficacy of the novel HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants infected with multi-drug resistant HIV-1 (BRIGHTE study) 72
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 72
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 71
Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy 71
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 71
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 71
Testosterone in males with COVID-19: A twelve-month cohort study 70
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 70
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 70
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 68
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 68
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 68
Subclinical myocardial dysfunction in patients recovered from COVID-19 68
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 67
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination 67
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 67
Prior Neisseria meningitidis (Nm) proctitis does not prevent Neisseria gonorrhoeae (Ng) proctitis among men who have sex with men (MSM) 66
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial 66
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients 66
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study 66
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 66
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 66
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient 65
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 65
Response to combination antiretroviral therapy: Variation by age 65
Bictegravir 65
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study 65
HIV-DNA undetectability during chronic HIV infection: Frequency and predictive factors 65
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 65
Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy) 64
Risk of Cardiovascular Diseases or Mortality in People with Higher Values of HIV-1 DNA 64
A RELATIVELY SLOW RISK OF DISEASE PROGRESSION IN HIV-POSITIVE PATIENTS WITH INDOLENT INFECTION HAS BEEN FOUND IN THE ICONA COHORT 64
Severely low testosterone in males with COVID-19: a case-control study 64
Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective 63
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults 63
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 62
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 62
HIV viral load monitoring during monkeypox virus infection among people with HIV 62
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir 62
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study 62
Beyond stigma: Monkeypox infection in a 27-year-old woman 61
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 60
Probable West Nile Virus hepatitis: Case report 60
Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report 60
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial 60
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. 60
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 60
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia 60
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure 59
Sexually Transmitted Enteric Infections in Men Who Have Sex With Men Living With HIV Over 8 Years of Follow-up 59
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV 59
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 59
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 59
Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis 59
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids 58
Isolated monkeypox proctitis among men who have sex with men 58
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice 58
Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men 58
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 58
Totale 9.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 233.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 233.430
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 51 11 131 5 0 7 4
2021/2022417 1 0 0 137 26 29 36 64 36 29 16 43
2022/20232.835 1.206 552 220 27 36 257 175 185 99 19 35 24
2023/20242.162 45 66 641 171 178 410 59 180 8 45 113 246
2024/20259.554 1.078 150 178 281 363 852 2.013 777 1.368 1.050 587 857
2025/202614.207 2.115 2.342 2.648 4.230 2.273 599 0 0 0 0 0 0
Totale 29.840